1. Home
  2. VIR vs SIBN Comparison

VIR vs SIBN Comparison

Compare VIR & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • SIBN
  • Stock Information
  • Founded
  • VIR 2016
  • SIBN 2008
  • Country
  • VIR United States
  • SIBN United States
  • Employees
  • VIR N/A
  • SIBN N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • SIBN Medical/Dental Instruments
  • Sector
  • VIR Health Care
  • SIBN Health Care
  • Exchange
  • VIR Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • VIR 844.9M
  • SIBN 805.4M
  • IPO Year
  • VIR 2019
  • SIBN 2018
  • Fundamental
  • Price
  • VIR $5.23
  • SIBN $16.39
  • Analyst Decision
  • VIR Strong Buy
  • SIBN Strong Buy
  • Analyst Count
  • VIR 7
  • SIBN 5
  • Target Price
  • VIR $32.86
  • SIBN $24.40
  • AVG Volume (30 Days)
  • VIR 1.4M
  • SIBN 462.2K
  • Earning Date
  • VIR 07-31-2025
  • SIBN 08-04-2025
  • Dividend Yield
  • VIR N/A
  • SIBN N/A
  • EPS Growth
  • VIR N/A
  • SIBN N/A
  • EPS
  • VIR N/A
  • SIBN N/A
  • Revenue
  • VIR $20,861,000.00
  • SIBN $176,601,000.00
  • Revenue This Year
  • VIR N/A
  • SIBN $19.48
  • Revenue Next Year
  • VIR N/A
  • SIBN $16.86
  • P/E Ratio
  • VIR N/A
  • SIBN N/A
  • Revenue Growth
  • VIR N/A
  • SIBN 22.60
  • 52 Week Low
  • VIR $4.32
  • SIBN $11.70
  • 52 Week High
  • VIR $14.45
  • SIBN $20.05
  • Technical
  • Relative Strength Index (RSI)
  • VIR 50.23
  • SIBN 36.27
  • Support Level
  • VIR $5.02
  • SIBN $17.35
  • Resistance Level
  • VIR $5.34
  • SIBN $19.24
  • Average True Range (ATR)
  • VIR 0.25
  • SIBN 0.61
  • MACD
  • VIR 0.03
  • SIBN -0.40
  • Stochastic Oscillator
  • VIR 47.53
  • SIBN 2.00

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: